ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1754

Double-Negative T (DNT) Cell over-Expressing PD-1 and Helios Is Responsible for Lupus Tissue Injury in Systemic Lupus Erythematosus (SLE): Direct Proof That Increased Interferon Alpha (IFNα) Expression Is Sufficient to Induce SLE in Ifnα-Transgenic Mice

Ken Tsumiyama1, Chieri Akiyama2, Yumi Miyazaki1, Yasushi Miura2, Akira Hashiramoto2 and Shunichi Shiozawa1, 1Department of Medicine, Rheumatic Diseases Unit, Kyushu University Beppu Hospital, Beppu, Japan, 2Department of Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: interferons and lupus nephritis, SLE, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Animal Models - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Previous studies strongly suggest that interferon α (IFNα) may be the principal driver of SLE, where increased IFNα and IFNα-regulated gene transcripts explain many of the immune alterations seen in SLE patients. However, the causal relationship between IFNα and SLE remains speculative and direct evidence for this causal link is required for more effective intervention of the disease. To directly prove the role of IFNα in inducing SLE, we generated transgenic (Tg) mice that express IFNα under the control of the inducible doxycycline (Dox) promoter.

Methods:  The mouse IFNα a1 (mIFNα) cDNA inserted downstream of the TetOp promoter of pTet Splice vector to generate TetOp-mIFNα. TetOp-mIFNα was microinjected into fertilized eggs of C57BL/6 mice to obtain TetOp-mIFNα Tg mice. The mice were mated with EμSR-tTA Tg mice (FVB/N background), expressing the Tet-transactivator (tTA) gene downstream of the Ig heavy chain enhancer and SRα promoter (Felsher and Bishop, Mol Cell 4:199, 1999), resulting in lymphoid cell-specific gene expression (EμSR-tTA) to produce double transgenic TetOp-mIFNα/EμSR-tTA mice of a C57BL6/FVBN background (IFNα Tg C57BL6/FVBN mice). These mice produced IFNα 4 weeks after cessation of 50 μg/mL of Dox. This IFNα Tg mice were also back-crossed to make IFNα Tg mice of C57BL/6 background to guarantee the universality of the result.

Results:  IFNα expression alone was sufficient to induce disease with characteristics identical to SLE, i.e., serum anti-double stranded DNA (dsDNA) antibody, immune complexes (IC) and tissue injury including glomerulonephritis accompanied by IC deposition, alopecia, epidermal liquefaction, positive lupus-band skin test and classical splenic onion-skin lesions. In these mice, activated CD3+CD4–CD8– double-negative T (DNT) cells, which were also TCRαβ+B220+CD1d-teteramer–, expanded significantly. When transferred into naïve recipients, these DNT cells infiltrated to the glomeruli of transgenic mice and induced de novo glomerulonephritis and alopecia. These DNT cells had halted differentiation and massively accumulated at the DN1 stage in the thymus. The DNT cell was characterized by the over-expression of PD-1 and Helios, an indicator of autoreactive DNT cell of CD8 T cell origin as shown by Rodriguez-Rodriguez N et al (J Immunol 194:4207, 2015).

Conclusion:  The results show that increased expression of IFNα is sufficient to induce SLE, and that DNT cell expressing PD-1 and Helios may play important roles in lupus tissue injury. The study is in collaboration with Dr. Dean W Felsher (Stanford University, Division of Oncology, Department of Medicine and Pathology).


Disclosure: K. Tsumiyama, None; C. Akiyama, None; Y. Miyazaki, None; Y. Miura, None; A. Hashiramoto, None; S. Shiozawa, None.

To cite this abstract in AMA style:

Tsumiyama K, Akiyama C, Miyazaki Y, Miura Y, Hashiramoto A, Shiozawa S. Double-Negative T (DNT) Cell over-Expressing PD-1 and Helios Is Responsible for Lupus Tissue Injury in Systemic Lupus Erythematosus (SLE): Direct Proof That Increased Interferon Alpha (IFNα) Expression Is Sufficient to Induce SLE in Ifnα-Transgenic Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/double-negative-t-dnt-cell-over-expressing-pd-1-and-helios-is-responsible-for-lupus-tissue-injury-in-systemic-lupus-erythematosus-sle-direct-proof-that-increased-interferon-alpha-ifn%ce%b1-expr/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/double-negative-t-dnt-cell-over-expressing-pd-1-and-helios-is-responsible-for-lupus-tissue-injury-in-systemic-lupus-erythematosus-sle-direct-proof-that-increased-interferon-alpha-ifn%ce%b1-expr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology